The mutational signature profile of known and suspected human carcinogens in mice

Laura Riva1, Arun R Pandiri2, Yun Rose Li3

  • 1Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.

Nature Genetics
|September 29, 2020
PubMed

Insights

Environmental carcinogens rarely cause distinct cancer mutations. Most mutations arise from natural processes, though specific signatures link agents like 1,2,3-trichloropropane to human tumors.

Area of Science:

  • Environmental health
  • Genomics
  • Cancer research

Background:

  • Epidemiological studies link environmental agents to increased cancer risk.
  • Understanding the genomic impact of carcinogen exposure is crucial for public health.

Purpose of the Study:

  • To investigate the mutational landscape of tumors induced by various environmental carcinogens in mice.
  • To identify specific mutational signatures associated with carcinogen exposure.
  • To compare cross-species genomic alterations in tumors from exposed animals and humans.

Main Methods:

  • Chronic exposure of mice to 20 known or suspected human carcinogens.
  • Analysis of tumor genomes to identify mutations and mutational signatures.
  • Comparison of mouse tumor genomic data with human tumor genomes.

Main Results:

  • Most environmental agents did not generate distinct mutational signatures or increase overall mutation burden.
  • Mutations, including driver mutations, predominantly resulted from tissue-specific endogenous processes.
  • Identified signatures linked to cobalt and vinylidene chloride exposure.
  • Linked human signatures (SBS19 and SBS42) to 1,2,3-trichloropropane exposure and found them in human tumors.

Conclusions:

  • Carcinogen exposure has a limited impact on generating distinct mutational signatures.
  • Endogenous processes are the primary drivers of mutations in cancer, even under carcinogen exposure.
  • Specific mutational signatures can be linked to certain environmental agents, aiding in understanding human cancer etiology.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.7K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.2K
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.0K